Literature DB >> 659887

Structure and function of immunoglobulin domains. VII. Studies on the structural requirements of human immunoglobulin G for granulocyte binding.

D E Barnett Foster, K J Dorrington, R H Painter.   

Abstract

The ability of various fragments of human myeloma IgG1 to inhibit rosette formation between human anti-D-coated human red blood cells and human polymorphonuclear leukocytes has been investigated. Although IgG and Fc showed a dose-dependent inhibition of rosettes and Fc showed a dose-dependent inhibition of rosettes at equimolar concentrations, neither of the fragments corresponding to the Cgamma2 and Cgamma3 homology regions obtained by acid-tryptic cleavage of Fc was able to inhibit rosette formation. The pepsin fragment of Fc, pFc', which represents the complete Cgamma3 domain, was also unable to prevent rosette formation. Reduction and alkylation of IgG or Fc markedly diminished cytophilic activity as measured by this system. These data indicate that the site in human IgG1 bound by granulocytes is dependent on the full quaternary structure of Fc, a requirement in marked contrast to that noted for binding by macrophages and monocytes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659887

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Oxidative cross-linking of immune complexes by human polymorphonuclear leukocytes.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Interactions of monomeric IgG bearing covalently bound C3b with polymorphonuclear leucocytes.

Authors:  A Malbran; M M Frank; L F Fries
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

3.  Isolation and identification of a biologically active peptide derived from the CH3 domain of human IgG1.

Authors:  E L Morgan; T E Hugli; W O Weigle
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

4.  Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region.

Authors:  M Klein; N Haeffner-Cavaillon; D E Isenman; C Rivat; M A Navia; D R Davies; K J Dorrington
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

5.  The expression of Fc receptors on guinea-pig peritoneal macrophages and neutrophils.

Authors:  K Coupland; R G Leslie
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

6.  Proteolysis of human IgG by human polymorphonuclear leucocyte elastase produces an Fc fragment with in vitro biological activity.

Authors:  H E Prince; J D Folds; J K Spitznagel
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

Review 7.  Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function.

Authors:  Hongcheng Liu; Kimberly May
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

8.  Phagocytosis of target particles bearing C3b-IgG covalent complexes by human monocytes and polymorphonuclear leucocytes.

Authors:  L F Fries; S A Siwik; A Malbran; M M Frank
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

9.  Characterization of a complement-fragment-C5a-stimulated calcium-influx mechanism in U937 monocytic cells.

Authors:  P N Monk; L J Partridge
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

10.  Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.